Uptake Medical, Inc.: Series C $35M

Posted in I - Series C, Q - 4Q11, R - WEST, X - COPD, X - Device (Pulmonary), X - Emphysema, XX - CA

Uptake Medical (Tustin, CA) a development-stage medical device company focused on non-surgical treatments for severe emphysema, COPD and lung diseases, closed a $35M Series C financing. Participants include Affinity Capital, Arboretum Ventures, GBS Venture Partners, Onset Ventures, Prism VentureWorks, Maverick Captial and WRF Capital.

Aug

2011

OrSense, Ltd.: Series D $18M

Posted in I - Series D, Q - 2Q11, R - INTERNATIONAL, X - Device (Monitoring), X - Device (Oxygen), X - Device (Pulmonary)

OrSense (Israel) a commercial-stage medical device company focused on non-invasive measurements of oxygen saturation, hemoglobin, glucose and other blood parameters, closed $18M Series D financing. Participants include Israel HealthCare Ventures, Star Ventures and Lewis Trust Private Equity.

Apr

2011

Veniti, Inc.: Series A $14.5M

Posted in I - Series A, Q - 1Q11, R - MID WEST, X - Device (Cardiology), X - Device (Pulmonary), X - Device (Vascular), XX - MO

Veniti (Saint Louis, MO) a development-stage medical device company focused on iliac vein outflow obstruction, closed a $13.5M Series A financing. Participants include Baird Venture Partners and H&Q Healthcare Investors.

Mar

2010

Pulmonx, Inc.: Series C $32M

Posted in I - Series C, Q - 1Q10, R - WEST, X - Device (COPD), X - Device (Pulmonary), XX - CA

Pulmonx (Redwood City, CA) a commercial-stage medical device company focused on minimally invasive devices for the diagnosis and treatment of COPD and other pulmonary disorders, closed a $32M Series C financing. Participants include HealthCap, Kleiner Perkins Caufield & Byers, De Novo Ventures, Latterell Venture Partners, MedVenture Associates, Montreux Equity Partners and Posco BioVentures.

to top of page...